A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...
Vous n'êtes pas connecté
A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The medication, tirzepatide, is sold under the name Mounjaro for diabetes and Zepbound for obesity. Researchers shared their findings at ENDO 2025, a major medical conference held […] The post New obesity drug may slow breast cancer growth appeared first on Knowridge Science Report.
A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...
A new study has found that an anti-obesity drug called tirzepatide, which is sold under the names Mounjaro for diabetes and Zepbound for obesity, may...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth...
In a new mouse-model study presented at bENDO 2025/b, the researchers observed that tirzepatide, a drug that is approved to treat type 2 diabetes
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro...
A new preclinical study from Weill Cornell Medicine reveals that linoleic acid, a type of omega-6 fatty acid commonly found in seed oils and animal...
A new preclinical study from Weill Cornell Medicine reveals that linoleic acid, a type of omega-6 fatty acid commonly found in seed oils and animal...
New research suggests that eating less just two days a week could be more helpful than other popular diet plans for people with obesity and type 2...
New research suggests that eating less just two days a week could be more helpful than other popular diet plans for people with obesity and type 2...
MONDAY, July 14, 2025 — Good news for women of a certain age: Hormone replacement therapy for menopause appears to boost the effectiveness of GLP-1...